Delivery Order V797D70255-36C26226N0818
Award Date 7/30/26
Potential Completion Date 7/29/27
Potential Value $51K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>Veterans Integrated Service Network 5 issued a delivery order to Galderma Laboratories, L.P. on May 21, 2026, with a ceiling value of $31,800 for Nemluvio 30 mg, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).</p> <p>Place of performance is Carrollton, TX. Ultimate completion date is May 22, 2026. The order is priced firm fixed price with no set-aside applied.</p>
- The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a delivery order valued at $31,800 to Galderma Laboratories, L.P. for the supply of Nemluvio 30 mg, an injectable pharmaceutical product. The contract was awarded on March 18, 2026, with an ultimate completion date of March 20, 2026, reflecting the time-sensitive nature of pharmaceutical supply to VA healthcare operations. This delivery order operates under a firm fixed-price arrangement with no...
- This delivery order awards $31.8K to Galderma Laboratories, L.P. for the supply of Nemluvio 30 mg, an injectable pharmaceutical product, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is funded by Veterans Integrated Service Network 5 (VISN 5), a civilian component of the Department of Veterans Affairs, with performance occurring in Carrollton, Texas. The award employs a firm fixed-price structure with no set-aside designation and an ultimate completion...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 19 to Galderma Laboratories, L.P., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract has a ceiling value of $18,377.86 and is for the delivery of 6 units of the injectable pharmaceutical product NEMOLIZUMAB CCP 30MG INJ. The contract has a period of performance from the award date of October 18, 2024 through March 31, 2025. There is...
- This federal contract award is for the delivery of NEMLUVIO 30 MG, an injectable pharmaceutical product, to the Veterans Integrated Service Network 5 (VISN 5), a division of the U.S. Department of Veterans Affairs (VA). The $24,905.28 firm fixed-price contract was awarded to Galderma Laboratories, L.P., a foreign-owned, for-profit pharmaceutical manufacturer, on August 22, 2025. The contract has an ultimate completion date of August 26, 2025 and is placed under the Pharmaceuticals and Drugs...
- <p>The Defense Logistics Agency issued a $2,033.08 delivery order to AmerisourceBergen Drug Corp on April 16, 2026, for Nemluvio 30 mg pens, with final delivery due May 7, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside.</p>
- The Defense Logistics Agency issued a $2,033.08 delivery order to AmerisourceBergen Drug Corp on April 10, 2026, for Nemluvio 30 mg pens, with an ultimate completion date of May 1, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999.999 billion indefinite delivery contract through December 2026 that provides pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order is...
- <p>The Defense Logistics Agency issued a $2,033.08 delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for Nemluvio 30 mg pens, with final delivery due April 22, 2026.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- <p>The Defense Logistics Agency issued a $2,033.08 delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for Nemluvio 30 mg pens, with ultimate completion by March 26, 2026.</p> <p>The order is issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 global pharmaceutical supply vehicle running through December 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no set-aside.</p>
- The Defense Logistics Agency issued a $2,033.08 delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for Nemluvio 30 mg pens. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D70255Federal Supply Schedule
- V797D70255-36C26226N0818Delivery Order
Veterans Integrated Service Network 22 issued a $50,880 delivery order to Galderma Laboratories, L.P. on July 30, 2026, for emergency supply of Nemluvio 30 mg (nemolizumab) injectable pharmaceutical products under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Carrollton, TX. The order is firm fixed price with an ultimate completion date of July 29, 2027. No set-aside was used. Galderma supplies injectable pharmaceutical products to the VA exclusively through FSS-61-IB.
Generated 7/30/26, 10:49 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.9k | 7/28/26 |